CKCourtney Keeton

Courtney Keeton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Courtney Keeton has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Client‐rated facilitators and barriers to long‐term youth anxiety disorder recovery

    by Elizabeth P. Casline, Robert R. Ogle, Tara S. Peris, Philip C. Kendall, John Piacentini, Scott N. Compton, Courtney Keeton, Golda S. Ginsburg

    Objective: This study examined client ratings of 26 facilitators and barriers to anxiety improvement approximately 6 years after randomization to treatment for anxiety.Method: 319 youth (average 17.12 years old; 82.1% Caucasian; 58.6% female) participated in the longitudinal follow‐up study to child and adolescent anxiety multimodal study (CAMS), a randomized controlled trial of medication, cognitive‐behavioral therapy (CBT), combination, and placebo.Results: Correcting for multiple comparisons, CBT components (i.e., problem solving, changing unhelpful thoughts, relaxation skills) were rated significantly more helpful among youth without, versus with, an anxiety disorder at follow‐up. Barriers that differentiated youth with and without an anxiety disorder included being bullied and difficulty applying therapy content to new situations. Comparisons between youth with different anxiety disorder trajectories (e.g., stable remission, relapsed, or chronically ill) also revealed several differences.Conclusion: Findings suggest that client‐rated facilitators and barriers covary with anxiety disorder recovery and may serve as useful tools when evaluating long‐term treatment efficacy.


  • Long-term Service Use Among Youths Previously Treated for Anxiety Disorder

    by Tara S. Peris, Catherine A. Sugar, Michelle S. Rozenman, John T. Walkup, Anne Marie Albano, Scott Compton, Dara Sakolsky, Golda Ginsburg, Courtney Keeton, Philip C. Kendall, et al.


  • Open Access

    The p Factor Consistently Predicts Long-Term Psychiatric and Functional Outcomes in Anxiety-Disordered Youth

    by Matti Cervin, Lesley A. Norris, Golda Ginsburg, Elizabeth A. Gosch, Scott N. Compton, John Piacentini, Anne Marie Albano, Dara Sakolsky, Boris Birmaher, Courtney Keeton, et al.


  • Mood and suicidality outcomes 3–11 years following pediatric anxiety disorder treatment

    by Courtney P. Keeton, Nicole E. Caporino, Philip C. Kendall, Satish Iyengar, Phyllis Lee, Tara Peris, Dara Sakolsky, John Piacentini, Scott N. Compton, Anne Marie Albano, et al.

    Youth anxiety interventions have potential to reduce risk for depression and suicidality. This naturalistic follow-up of the multi-site, comparative treatment trial, inking and behavior, and depressive symptoms 3-11 years (mean 6.25 years) following 12-week evidence-based youth anxiety treatment. Participants (N = 319; 10-26 years, mean 17 years) completed semiannual questionnaires and annual diagnostic interviews for 4 years. One-fifth (20.4%) of the sample met DSM-IV criteria for a mood disorder, 32.1% endorsed suicidal ideation, and 8.2% reported suicidal behavior. Latent class growth analysis yielded two linear trajectories of depressive symptoms, and 85% of the sample demonstrated a persistent low-symptom course over seven assessments. Child/Adolescent Anxiety Multimodal Study (CAMS) 12-week treatment outcome (positive response, remission) and treatment condition (cognitive behavior therapy [CBT], medication, CBT + medication, pill placebo) were not associated with subsequent mood disorder or suicidal thinking. CAMS remission predicted absence of suicidal behavior, and treatment response and remission predicted low depressive symptom trajectory. Greater baseline self-reported depressive symptoms predicted all long-term mood outcomes, and more negative life events predicted subsequent mood disorder, depressive symptom trajectory, and suicidal ideation. Effective early treatment of youth anxiety, including CBT, medication, or CBT + medication, reduces risk for subsequent chronic depressive symptoms and suicidal behavior. Attention to (sub)clinical depressive symptoms and management of negative life events may reduce odds of developing a mood disorder, chronic depressive symptoms, and suicidality. Findings contribute to evidence that early intervention for a primary disorder can serve as secondary prevention.